Volume 1, Issue 1
Editorialp. 1-2
Pharmaceutical Bioprocessing: a new voice for the biopharmaceuticals community
Author(s): Seongkyu Yoon
Editorialp. 11-13
Biologics 2.0: can omics technology improve mammalian cell-based manufacturing?
Author(s): Trent P Munro
News and Viewsp. 15-17
GlaxoSmithKline launches continuous processing technology
Author(s): GlaxoSmithKline
Research Articlep. 19-17
High expression of the Aspartate Glutamate carrier Aralar1 favors lactate consumption in CHO cell culture
Author(s): Francesca Zagari, Matthieu Stettler, Lucia Baldi, Herv Broly, Florian M Wurm & Martin Jordan
Perspective Articlep. 29-50
Developability assessment as an early de-risking tool for biopharmaceutical development
Author(s): Jesus Zurdo
Review Articlep. 51-69
Applying quality by design to glycoprotein therapeutics: experimental and computational efforts of process control
Author(s): Philip M Jedrzejewski, Ioscani Jimenez del Val,Karen M Polizzi and Cleo Kontoravdi
Review Articlep. 71-87
Generation of monoclonal antibody-producing mammalian cell lines
Author(s): Steven CL Ho, Yen Wah Tong & Yuansheng Yang*
Review Articlep. 89-104
Deciphering O-glycomics for the development and production of biopharmaceuticals
Author(s): Peiqing Zhang*, Tianhua Wang, Muriel Bardor & Zhiwei Song
Review Articlep. 105-122
Quality by design for biopharmaceuticals: a historical review and guide for implementation
Author(s): Phillip Elliott, Sam Billingham, Jingxiu Bi & Hu Zhang
